Skip to main navigation

HOME
ABOUT ENZON
ROYALTY PRODUCTS
INVESTORS & MEDIA
Investor Relations
CONTACT US

Request Information
Email Alerts
Download Library
RSS News Feeds

Shareholder Tools

Downloads

Print

Downloads

Categories

Year

Mar 17, 2011

Enzon Appoints Richard Mulligan, Ph.D. Vice-Chairman of the Board; Adopts Majority Vote Standard for Election of Directors 12.9 KB

Feb 17, 2011

Enzon Reports 2010 Results 101.8 KB

Feb 10, 2011

Enzon to Release Fourth Quarter 2010 Earnings on Thursday, February 17, 2011; Conference Call and Webcast to Follow 9.5 KB

Jan 10, 2011

Enzon to Begin Phase 1 Study of Novel Androgen Receptor mRNA Antagonist in Castration-Resistant Prostate Cancer 13.6 KB

Dec 21, 2010

Enzon Board Authorizes Share Repurchase Program 10.9 KB

Dec 15, 2010

Enzon Announces the Initiation of Two Phase I Studies in Collaboration with the National Cancer Institute 65.8 KB

Nov 17, 2010

Enzon Presents Data at 2010 EORTC-NCI-AACR Meeting 67.5 KB

Nov 11, 2010

Code of Conduct and Corporate Values 194.7 KB

Nov 02, 2010

Enzon Reports Third Quarter 2010 Results 32.5 KB

Nov 02, 2010

Enzon Pharmaceuticals Awarded $1.2 Million in Grants under QTDP Program 10.6 KB

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

©2025 Enzon Pharmaceuticals, Inc., All Rights Reserved.